Loading...
Judul : Biotech company raises $360 million for cancer-detecting blood test
link : Biotech company raises $360 million for cancer-detecting blood test
Biotech company raises $360 million for cancer-detecting blood test
A California-based biotech company raised $360 million to fund a new early warning system that could detect cancer with a simple blood test. Guardant Health raised the funding for Guardant360, a blood test that measures genetic biomarkers for tumors, or a “liquid biopsy.” The blood would detect “circulating tumor DNA (ctDNA),” tiny bits of DNA a tumor releases in the blood stream at it grows. According to the National Human Genome Research Institute, ctDNA tracking is a less-invasive and safer alternative to a tumor biopsy. The ctDNA can often be used to detect cancer as it’s growing, increasing the chances it’s caught early.…
This story continues at The Next Web
✍ Sumber Pautan : ☕ The Next Web
Kredit kepada pemilik laman asal dan sekira berminat untuk meneruskan bacaan sila klik link atau copy paste ke web server : http://ift.tt/2pGRXtK
(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!
Demikianlah Artikel Biotech company raises $360 million for cancer-detecting blood test
Sekianlah artikel Biotech company raises $360 million for cancer-detecting blood test kali ini, mudah-mudahan bisa memberi manfaat untuk anda semua. baiklah, sampai jumpa di postingan artikel lainnya.
Anda sekarang membaca artikel Biotech company raises $360 million for cancer-detecting blood test dengan alamat link https://malaysiaonthehome.blogspot.com/2017/05/biotech-company-raises-360-million-for.html
0 Response to "Biotech company raises $360 million for cancer-detecting blood test"
Catat Ulasan